American Century Companies’s Zentalis Pharmaceuticals ZNTL Stock Holding History

American Century Companies's ZNTL Position: Q1 2026 in Review

American Century Companies increased its Zentalis Pharmaceuticals (ZNTL) stake by 277% in Q1 2026, buying an estimated $92.2K and bringing the position to 48,572 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #2771.

American Century Companies first reported a position in ZNTL in Q2 2024 and has held it in 6 quarters since. 102 funds tracked by Wall St. Rank hold ZNTL as of Q1 2026.

• American Century Companies held 48,572 shares of Zentalis Pharmaceuticals worth $114K as of Q1 2026.
• American Century Companies bought 35,692 Zentalis Pharmaceuticals shares in Q1 2026, an estimated $92.2K.
• Zentalis Pharmaceuticals made up ﹤0.01% of American Century Companies's portfolio in Q1 2026, its #2771 holding.
• American Century Companies first reported a position in Zentalis Pharmaceuticals in Q2 2024 and has held it in 6 quarters since.
• 102 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.